David I. Johnson's most recent trade in Firefly Neuroscience Inc. was a trade of 557,885 Common Stock, par value $0.0001 per share done . Disclosure was reported to the exchange on Oct. 22, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Firefly Neuroscience Inc. | David I. Johnson | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2024 | 557,885 | 557,885 | - | 0 | Common Stock, par value $0.0001 per share | |
Enveric Biosciences Inc | David I. Johnson | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 1,315,807 | 1,315,807 | - | - | Restricted Stock Units | |
Enveric Biosciences Inc | David I. Johnson | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 53,192 | 1,368,999 | - | - | Restricted Stock Units |